Company Overview and News

Trading ideas: Westports, Gabungan AQRS, Atrium REIT, RCE Capital

KUALA LUMPUR: JF Apex Research expects Westports Holdings Bhd , Gabungan AQRS, Atrium REIT, RCE Capital Bhd and Daya Materials to see trading interest today following their latest corporate results and news.
Upvote Downvote

Higher interest boosts RCE Capital profits

PETALING JAYA: Higher interest and fee income is helping to boost profits at RCE Capital Bhd , with the company expected to better its previous financial year performance amid steady demand for personal loans.
Upvote Downvote

Malaysia’s top 40 richest people

LAST year was dotted by the return of higher commodity prices and better economic growth. The world’s economies on average are back in business as growth rates and trade have started to improve once again after some period of uncertainty caused by a cooling China economy and also the slump in global crude oil prices.
Upvote Downvote

UEM Sunrise 'hold', MYEG 'neutral', Poh Huat 'buy', Comfort Gloves 'buy'

UEM Sunrise Bhd has proposed the disposal of 28.995 acres of freehold agricultural lands in Iskandar Puteri, Johor Baru, to Kimlun Corp Bhd for a total consideration of RM82.1mil.
Upvote Downvote

Bursa ends lower on profit-taking

2017-03-31 themalaymailonline
KUALA LUMPUR, March 31 ― Bursa Malaysia closed lower today on profit-taking in heavyweights led by telecommunications and industrial stocks and in line with most Asian peers, dealers said.
Upvote Downvote

KLCI remains lacklustre, in line with regional markets

2017-02-17 theedgemarkets
KUALA LUMPUR (Feb 17): The FBM KLCI managed to eke out negligible gains at the midday break today, in line with the lacklustre regional markets as selling persisted at the local market.
Upvote Downvote

Maybank IB raises earnings outlook for RCE Capital

Bank of England testing palm and coconut oils to make new bank notes after protests for using animal-fat
Upvote Downvote

Maybank Research raises earnings outlook for RCE Capital

Bank of England testing palm and coconut oils to make new bank notes after protests for using animal-fat
Upvote Downvote

Trading ideas: Heineken, Boustead, Gas Malaysia, RCE Capital, DNex, ECS ICT

Bank of England testing palm and coconut oils to make new bank notes after protests for using animal-fat
Upvote Downvote

Heineken, Boustead Plantations, BLand, Gas Malaysia, RCE Capital, Wah Seong, Wong Engineering and DNeX

2017-02-15 theedgemarkets
KUALA LUMPUR (Feb 15): Based on corporate announcements and news flow today, companies that will be in focus tomorrow (Thursday, Feb 16) may include: Heineken Malaysia Bhd, Boustead Plantations Bhd, Berjaya Land Bhd (BLand), Gas Malaysia Bhd, RCE Capital Bhd, Wah Seong Corp Bhd, Wong Engineering Corp Bhd and Dagang NeXchange Bhd (DNeX). 
Upvote Downvote

Top 40 richest in Malaysia: 21-25

KIAN CHONG, 40, is the grandson of the late Tan Sri Loh Boon Siew, who in his lifetime was the richest man in Penang.
Upvote Downvote

Azman’s journey with AMMB

THE planned retirement of Tan Sri Azman Hashim from a number of boards he sits on signals an impending end of a generation of entreprenuers who have built from scratch some of Malaysia’s largest companies.
Upvote Downvote

Breakfast briefing: Monday, January 9

MarketWatch: Investors puzzled over whether US interest rates are rising due to a stronger economy or because of fears about inflation might look at the recent gains in REITs for some useful guidance. - Reuters Energy Oil prices fell early on Monday as Iran increased exports undermining efforts by other oil producers to curb a global fuel supply overhang and as US drillers increased activity for a 10th week.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...